The role of insulin-like growth factor-1 in bone remodeling: A review
J Fang, X Zhang, X Chen, Z Wang, S Zheng… - International Journal of …, 2023 - Elsevier
Insulin-like growth factor (IGF)-1 is a polypeptide hormone with vital biological functions in
bone cells. The abnormal expression of IGF-1 has a serious effect on bone growth …
bone cells. The abnormal expression of IGF-1 has a serious effect on bone growth …
A comprehensive review on environmental pollutants and osteoporosis: Insights into molecular pathways
PS Priya, PP Nandhini, J Arockiaraj - Environmental Research, 2023 - Elsevier
A significant problem that has an impact on community wellbeing is environmental pollution.
Environmental pollution due to air, water, or soil pollutants might pose a severe risk to global …
Environmental pollution due to air, water, or soil pollutants might pose a severe risk to global …
[HTML][HTML] Unique macrophage phenotypes activated by BMP signaling in breast cancer bone metastases
CL Ihle, DM Straign, JA Canari, KC Torkko, KL Zolman… - JCI insight, 2024 - ncbi.nlm.nih.gov
Metastatic breast cancer (mBC) tissue in bone was systematically profiled to define the
composition of the tumor microenvironment. Gene expression identified a high myeloid …
composition of the tumor microenvironment. Gene expression identified a high myeloid …
[HTML][HTML] Advances in the application of bone morphogenetic proteins and their derived peptides in bone defect repair
Q Liu, X Peng, X Liu, X Mou, Y Guo, L Yang… - Composites Part B …, 2023 - Elsevier
BMPs are members of the transforming growth factor-β (TGF-β) superfamily and have been
extensively studied due to their excellent osteoinductive ability and multiple functions …
extensively studied due to their excellent osteoinductive ability and multiple functions …
In silico engineering and simulation of RNA interferences nanoplatforms for osteoporosis treating and bone healing promoting
A Imanpour, H Kolahi Azar, D Makarem… - Scientific Reports, 2023 - nature.com
Osteoporosis is a bone condition characterized by reduced bone mineral density (BMD),
poor bone microarchitecture/mineralization, and/or diminished bone strength. This …
poor bone microarchitecture/mineralization, and/or diminished bone strength. This …
Research progress of design drugs and composite biomaterials in bone tissue engineering
X Guo, P Song, F Li, Q Yan, Y Bai, J He… - International Journal …, 2023 - Taylor & Francis
Bone, like most organs, has the ability to heal naturally and can be repaired slowly when it is
slightly injured. However, in the case of bone defects caused by diseases or large shocks …
slightly injured. However, in the case of bone defects caused by diseases or large shocks …
Mitochondria: a breakthrough in combating rheumatoid arthritis
S Li, C Huo, A Liu, Y Zhu - Frontiers in Medicine, 2024 - frontiersin.org
As a chronic autoimmune disease with complex aetiology, rheumatoid arthritis (RA) has
been demonstrated to be associated with mitochondrial dysfunction since mitochondrial …
been demonstrated to be associated with mitochondrial dysfunction since mitochondrial …
14-3-3ζ suppresses RANKL signaling by destabilizing TRAF6
R Ayyasamy, S Fan, P Czernik, B Lecka-Czernik… - Journal of Biological …, 2024 - jbc.org
Macrophages are essential regulators of inflammation and bone loss. Receptor activator of
nuclear factor-κβ ligand (RANKL), a pro-inflammatory cytokine, is responsible for …
nuclear factor-κβ ligand (RANKL), a pro-inflammatory cytokine, is responsible for …
Osteoclast-driven osteogenesis, bone remodeling and biomaterial resorption: A new profile of bmp2-cpc-induced alveolar bone regeneration
H Shen, Y Zhuang, C Zhang, C Zhang, Y Yuan… - International journal of …, 2022 - mdpi.com
This bedside-to-bench study aimed to systematically investigate the value of applying BMP2-
loaded calcium phosphate cement (BMP2-CPC) in the restoration of large-scale alveolar …
loaded calcium phosphate cement (BMP2-CPC) in the restoration of large-scale alveolar …
Novel strategies for spatiotemporal and controlled BMP-2 delivery in bone tissue engineering
J Qi, H Wu, G Liu - Cell Transplantation, 2024 - journals.sagepub.com
Bone morphogenetic protein-2 (BMP-2) has been commercially approved by the Food and
Drug Administration for use in bone defects and diseases. BMP-2 promotes osteogenic …
Drug Administration for use in bone defects and diseases. BMP-2 promotes osteogenic …